FSD Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc. has engaged Totaligent, Inc. for a 30-day term to boost market awareness and shareholder engagement using Totaligent’s extensive investor network. Additionally, the company has settled debts by issuing 650,000 shares to creditors and continues to develop its biopharmaceutical portfolio, focusing on neurodegenerative and metabolic disorders, while retaining a significant tax loss carry forward and a stake in Celly Nutrition Corp.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
